Calpain 10 gene and laryngeal cancer: A survival analysis

Head and Neck

Volumn 33, Issue 1, 2011, Pages 72-76

  Moreno Luna, Ramón ^a   Abrante, Antonio ^a   Esteban, Francisco ^a   González Moles, Miguel Angel ^a   Delgado Rodríguez, Miguel ^b   Sáez, María Eugenia ^c   González Pérez, Antonio ^c   Ramírez Lorca, Reposo ^c   Real, Luis Miguel ^c   Ruiz, Agustín ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

calpains; CAPN10; laryngeal cancer; polymorphism; UCSNP 63

Indexed keywords

CALPAIN 10;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; GENOTYPE; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; UNIVARIATE ANALYSIS;

AGED; ALLELES; ANALYSIS OF VARIANCE; CALPAIN; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SPAIN; SURVIVAL ANALYSIS;

EID: 78651365431     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21404     Document Type: Article

References (32)

1. Parkin DM, Whelan S, Ferlay J, Storm H,. In: Cancer incidence in five continents, vols. IeVIII. Lyon: IARC Cancer Base No. 7; 2005.
2. Brugere J, Guenel P, Leclerc A, Rodriguez J,. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986; 57: 391-395.
3. Esteban F, Royo JL, González-Moles MA, et al. CAPN10 alleles modify laryngeal cancer risk in the Spanish population. Eur J Surg Oncol 2008; 34: 94-99.
4. Chang AR, Wu HG, Park CI, Jun YK, Kim CW,. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer. Head Neck 2008; 30: 852-857.
5. Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I,. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005; 262: 890-898.
6. Baek SK, Jung KY, Lee SH, et al. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma. Laryngoscope 2009; 119: 1325-1330.
7. Zatz M, Starling A,. Calpains and disease. N Engl J Med 2005; 352: 2413-2423.
8. Liu X, Van Vleet T, Schnellmann RG,. The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol 2004; 44: 349-370.
9. Frances CP, Conde MC, Saez ME, et al. Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility. J Gastroenterol Hepatol 2007; 22: 2298-2302.
10. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-175.
11. Evans JC, Frayling TM, Cassell PG, et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001; 69: 544-552.
12. Sasieni PD,. From genotypes to genes: doubling the sample size. Biometrics 1997; 53: 1253-1261.
13. Sun GW, Shook TL, Kay GL,. Inappropriate use of bivariable analysis to screen risk factors for use in multivariate analysis. J Clin Epidemiol 1996; 49: 907-916.
14. Mickey RM, Greenland S,. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125-137. (Pubitemid 19030705)
15. Maldonado G, Greenland S,. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138: 923-936.
16. Emori Y, Kawasaki H, Imajoh S, Imahori K, Suzuki K,. Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci U S A 1987; 84: 3590-3594.
17. Maki M, Bagci H, Hamaguchi K, Ueda M, Murachi T, Hatanaka M,. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J Biol Chem 1989; 264: 18866-18869.
18. Kawasaki H, Emori Y, Imajoh-Ohmi S, Minami Y, Suzuki K,. Identification and characterization of inhibitory sequences in four repeating domains of the endogenous inhibitor for calcium-dependent protease. J Biochem 1989; 106: 274-281.
19. Carragher NO, Fincham VJ, Riley D, Frame MC,. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J Biol Chem 2001; 276: 4270-4275.
20. Huttenlocher A, Palecek SP, Lu Q, et al. Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 1997; 272: 32719-32722.
21. Murray SS, Grisanti MS, Bentley GV, Kahn AJ, Urist MR, Murray EJ,. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells. Exp Cell Res 1997; 233: 297-309.
22. Nakagawa T, Yuan J,. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000; 150: 887-894.
23. Patel YM, Lane MD,. Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J Biol Chem 2000; 275: 17653-17660.
24. Cascorbi I, Henning S, Bröckmoller J, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res 2000; 60: 644-649.
25. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P,. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002; 23: 1229-1234.
26. Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P,. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 2001; 93: 1411-1418.
27. Bardakci F, Canbay E, Degerli N, Coban L, Canbay EI,. Relationship of tobacco smoking with GSTM1 gene polymorphism in laryngeal cancer. J Cell Mol Med 2003; 7: 307-312.
28. Izzo JG, Papadimitrakopoulou VA, Liu DD, et al. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 2003; 95: 198-205.
29. Gonzalez A, Abril E, Roca A, et al. Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients. J Clin Endocrinol Metab 2003; 88: 5529-5536.
30. Balkau B, Kahn HS, Courbon D, Eschwège E, Ducimetière P,. Paris Prospective Study. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study. Diabetes Care 2001; 24: 843-849.
31. Augustin LS, Gallus S, Franceschi S, et al. Glycemic index and load and risk of upper aero-digestive tract neoplasms (Italy). Cancer Causes Control 2003; 14: 657-662.
32. Jõźkõw P, Medraś M, Krecicki T, Zalesska-Krecicka M,. Hormonal markers of aging in men with laryngeal carcinoma. Head Neck 2005; 27: 243-247.